You can now use the comment section at the end of each page to discuss the topic and ask questions.

Note: For quick navigation, use the browser search function (e.g. Ctrl+F) and enter the variation category without the full stop (e.g. Q.II.b.3 -> qiib3).

Valid Version — C/2025/5045 (effective 16.01.2026)

Previous version is available here: Variations Guidelines 2013/C 223/01

Q. QUALITY CHANGES – Q.II. FINISHED PRODUCT – Q.II.h) Adventitious Agents Safety

#qiih1

Q.II.h.1 Update to the ‘Adventitious Agents Safety Evaluation’ information (Section 3.2.A.2)Conditions to be fulfilledDocumentation to be suppliedProcedure type
(a) Studies related to manufacturing steps investigated for the first time for one or more adventitious agents  II
(b) Replacement of obsolete studies related to manufacturing steps and adventitious agents already reported in the dossier   
1. with modification of risk assessment resulting in higher risk  II
2. with modification of risk assessment resulting in equivalent or lower risk 1, 2, 3IB
3. without modification of risk assessment 1, 3, 4IB
Documentation
1. Amendment of the relevant section(s) of the dossiers including the introduction of the new studies to investigate the capability of manufacturing steps to inactivate/reduce adventitious agents.
2. Justification that the studies modify the risk assessment resulting in equivalent or lower risk.
3. Amendment of product information (where applicable).
4. Justification that the studies do not modify the risk assessment.

Leave a Reply

Your email address will not be published. Required fields are marked *